Adoption of Dexmedetomidine in Different Doses at Different Timing in Perioperative Patients
Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requiremen...
Saved in:
Published in | BioMed research international Vol. 2022; no. 1; p. 4008941 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Hindawi
2022
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 2314-6133 2314-6141 2314-6141 |
DOI | 10.1155/2022/4008941 |
Cover
Abstract | Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People’s Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients. |
---|---|
AbstractList | Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia.
it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training).
495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4
g/(kg·h) rate), groups A2, B2, and C2 (0.6
g/(kg·h) rate), and groups A3, B3, and C3 (0.8
g/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups.
the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (
), but did not change significantly in groups A1, A2, and A3 (
); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (
); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (
).
the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8
g/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients. Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μ g/(kg·h) rate), groups A2, B2, and C2 (0.6 μ g/(kg·h) rate), and groups A3, B3, and C3 (0.8 μ g/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 ( P <0.05 ), but did not change significantly in groups A1, A2, and A3 ( P >0.05 ); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( P <0.05 ); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 ( P <0.05 ). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μ g/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients. Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia. Objective: it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training). Methods: 495 patients requiring surgical treatment in Xingtai People’s Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups. Results: the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05). Conclusion: the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients. Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia.Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic tone, with attenuation of the neuroendocrine and hemodynamic responses to anesthesia and surgery; it reduces anesthetic and opioid requirements; and causes sedation and analgesia.it was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training).OBJECTIVEit was to compare the perioperative effects of different doses of Dex at different timing in patients using Dex during the perioperative period adopting a medical data classification algorithm based on optimized semi-supervised collaborative training (Tri-training).495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups.METHODS495 patients requiring surgical treatment in Xingtai People's Hospital were randomly selected as the study subjects. The patients were divided into group A (used before induction), group B (used during induction), and group C (used after induction) according to different induction timing, with 165 cases in each group. Then, groups A, B, and C were divided into groups A1, B1, and C1 (0.4 μg/(kg·h) rate), groups A2, B2, and C2 (0.6 μg/(kg·h) rate), and groups A3, B3, and C3 (0.8 μg/(kg·h) rate) according to the dose used, with 55 cases in each group. Intraoperative anesthesia and postoperative adverse reactions were compared among the 9 groups.the similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05).RESULTSthe similarity between the Tri-training algorithm optimized by Naive Bayes (NB) classification algorithm and the actual classification (93.49%) was clearly higher than that by decision tree (DT) and K-nearest neighbor (kNN) classification algorithm (76.21%, 74.31%); heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) values decreased obviously after Dex used in groups B1, C1, B2, C2, B3, and C3 (P <0.05), but did not change significantly in groups A1, A2, and A3 (P >0.05); the proportion of patients with satisfactory Ramsay score in group A3 was distinctly superior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05); the incidence of adverse reactions in group A3 was significantly inferior than that in groups A1, A2, B1, B2, B3, C1, C2, and C3 (P <0.05).the optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients.CONCLUSIONthe optimization effect of NB classification algorithm was the best, and the injection of Dex at the injection rate of 0.8 μg/(kg·h) before induction of anesthesia could apparently improve the fluctuation of HR, SBP, and DBP during perioperative period, and effectively reduce the occurrence of adverse reactions in patients, with better sedative effect on patients. |
Audience | Academic |
Author | Qu, Zhenhua Xie, Jing Feng, Shiqiang |
AuthorAffiliation | Department of Anesthesiology, Xingtai People's Hospital, Xingtai, Hebei, China |
AuthorAffiliation_xml | – name: Department of Anesthesiology, Xingtai People's Hospital, Xingtai, Hebei, China |
Author_xml | – sequence: 1 givenname: Jing surname: Xie fullname: Xie, Jing organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn – sequence: 2 givenname: Shiqiang surname: Feng fullname: Feng, Shiqiang organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn – sequence: 3 givenname: Zhenhua orcidid: 0000-0003-4809-538X surname: Qu fullname: Qu, Zhenhua organization: Department of AnesthesiologyXingtai People’s HospitalXingtaiHebeiChinaxtrmyy.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35872874$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt9rFDEQx4NU7A_75rMs-CLUs_m1yealcPS0FQr2ob4JIZudXFN2kzPZq_rfm-Wu11rQvEzIfPL9zjBziPZCDIDQG4I_ElLXpxRTesoxbhQnL9ABZYTPBOFkb3dnbB8d53yHy2mIwEq8QvusbiRtJD9A3-ddXI0-hiq6agG_BuhgjIPvfIDKh2rhnYMEYawWMUOuzPjk6cYPPiwn7BqSjytIZvT3UF2XUPL5NXrpTJ_heBuP0LfPn27OL2dXXy--nM-vZpZLMc4YAdNZwC21om05JswwIxSpMWmIBc4Uda2ixkpBlZPMlaataa1tDXS0tewInW10V-u2NGCLdzK9XiU_mPRbR-P135ngb_Uy3mvFsGS8KQLvtwIp_lhDHvXgs4W-NwHiOmsqFOcUC6EK-u4ZehfXKZT2JorVQqlaPlJL04P2wcXiaydRPZekDIVIVhfq7dO6dwU_jKcAHzaATTHnBG6HEKynBdDTAujtAhScPsOtH8003eLu-399Otl8uvWhMz_9_y3-AIX8vsI |
CitedBy_id | crossref_primary_10_1155_2024_9862705 |
Cites_doi | 10.1111/pan.14248 10.1007/s11517-020-02159-z 10.3390/ani11113254 10.4103/aca.ACA_168_18 10.1016/j.compbiomed.2018.11.018 10.1253/circj.CJ-21-0131 10.4103/sja.SJA_653_17 10.1016/j.jbi.2019.103252 10.3934/mbe.2021418 10.1097/MD.0000000000014144 10.1001/jama.2019.0234 10.32604/cmes.2021.016728 10.12659/MSM.930197 10.5812/aapm.111272 10.1007/s12652-020-02883-2 10.4103/ija.IJA_168_21 10.4103/aer.AER_153_17 10.3892/etm.2020.8787 10.1001/jamasurg.2017.1505 10.1016/j.future.2020.03.039 10.1016/j.bjan.2020.08.005 10.1016/j.bbi.2020.10.008 10.1016/j.jcrc.2016.10.026 10.3390/molecules26123671 10.25122/jml-2019-0070 10.1007/s00432-019-03102-y 10.12659/MSM.929949 10.1016/j.ijcce.2020.12.004 10.3892/etm.2017.4335 10.4314/ahs.v18i4.48 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Jing Xie et al. COPYRIGHT 2022 John Wiley & Sons, Inc. Copyright © 2022 Jing Xie et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Jing Xie et al. 2022 |
Copyright_xml | – notice: Copyright © 2022 Jing Xie et al. – notice: COPYRIGHT 2022 John Wiley & Sons, Inc. – notice: Copyright © 2022 Jing Xie et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 – notice: Copyright © 2022 Jing Xie et al. 2022 |
DBID | RHU RHW RHX AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QO 7T7 7TK 7U7 7U9 7X7 7XB 88E 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU CWDGH DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 5PM |
DOI | 10.1155/2022/4008941 |
DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Middle East & Africa Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest Health & Medical Research Collection Middle East & Africa Database Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Toxicology Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2314-6141 |
Editor | Akhlaq, Muhammad |
Editor_xml | – sequence: 1 givenname: Muhammad surname: Akhlaq fullname: Akhlaq, Muhammad |
ExternalDocumentID | PMC9307348 A711331735 35872874 10_1155_2022_4008941 |
Genre | Retracted Publication Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | 04C 3V. 4.4 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJEY AAWTL ABDBF ABUWG ACIWK ACPRK ADBBV ADRAZ AENEX AFKRA AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS ARAPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BMSDO BPHCQ BVXVI CCPQU CWDGH DIK EAD EAP EAS EBD EBS ECF ECT EIHBH EMB EMK EMOBN ESX FYUFA GROUPED_DOAJ HCIFZ HMCUK HYE IAG IAO IEA IHR INH INR IOF ISR ITC KQ8 LK8 M1P M48 M7P ML0 ML~ OK1 P62 PIMPY PQQKQ PROAC PSQYO RHU RHW RHX RPM SV3 TUS UKHRP 0R~ 24P AAYXX ACCMX ACUHS ADOJX ALIPV CITATION EJD H13 PGMZT PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QL 7QO 7T7 7TK 7U7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c476t-31eadce0b2c6bb4013a3a69150181ce4392fb92ac7629f73f022cabccbaed2bc3 |
IEDL.DBID | M48 |
ISSN | 2314-6133 2314-6141 |
IngestDate | Thu Aug 21 14:30:55 EDT 2025 Thu Sep 04 19:07:29 EDT 2025 Fri Jul 25 12:04:04 EDT 2025 Tue Jun 17 22:02:41 EDT 2025 Mon Jul 21 06:00:42 EDT 2025 Thu Apr 24 22:59:41 EDT 2025 Tue Jul 01 01:56:06 EDT 2025 Sun Jun 02 18:52:04 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © 2022 Jing Xie et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c476t-31eadce0b2c6bb4013a3a69150181ce4392fb92ac7629f73f022cabccbaed2bc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Correction/Retraction-3 Academic Editor: Muhammad Akhlaq |
ORCID | 0000-0003-4809-538X |
OpenAccessLink | https://dx.doi.org/10.1155/2022/4008941 |
PMID | 35872874 |
PQID | 2693569957 |
PQPubID | 237798 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9307348 proquest_miscellaneous_2694420669 proquest_journals_2693569957 gale_infotracmisc_A711331735 pubmed_primary_35872874 crossref_primary_10_1155_2022_4008941 crossref_citationtrail_10_1155_2022_4008941 hindawi_primary_10_1155_2022_4008941 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-00-00 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – year: 2022 text: 2022-00-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | BioMed research international |
PublicationTitleAlternate | Biomed Res Int |
PublicationYear | 2022 |
Publisher | Hindawi John Wiley & Sons, Inc |
Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc |
References | e_1_2_8_27_2 e_1_2_8_28_2 e_1_2_8_29_2 e_1_2_8_23_2 e_1_2_8_24_2 e_1_2_8_25_2 e_1_2_8_26_2 e_1_2_8_9_2 e_1_2_8_2_2 e_1_2_8_1_2 e_1_2_8_4_2 e_1_2_8_3_2 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_21_2 e_1_2_8_22_2 e_1_2_8_16_2 Shetty R. M. (e_1_2_8_18_2) 2018; 2 e_1_2_8_17_2 e_1_2_8_19_2 e_1_2_8_12_2 e_1_2_8_13_2 e_1_2_8_14_2 e_1_2_8_15_2 e_1_2_8_31_2 e_1_2_8_30_2 e_1_2_8_10_2 e_1_2_8_11_2 38230094 - Biomed Res Int. 2024 Jan 9;2024:9862705. doi: 10.1155/2024/9862705 |
References_xml | – ident: e_1_2_8_27_2 doi: 10.1111/pan.14248 – ident: e_1_2_8_14_2 doi: 10.1007/s11517-020-02159-z – volume: 2 year: 2018 ident: e_1_2_8_18_2 article-title: BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization publication-title: The Cochrane Database Of Systematic Reviews – ident: e_1_2_8_31_2 doi: 10.3390/ani11113254 – ident: e_1_2_8_24_2 doi: 10.4103/aca.ACA_168_18 – ident: e_1_2_8_20_2 doi: 10.1016/j.compbiomed.2018.11.018 – ident: e_1_2_8_16_2 doi: 10.1253/circj.CJ-21-0131 – ident: e_1_2_8_7_2 doi: 10.4103/sja.SJA_653_17 – ident: e_1_2_8_13_2 doi: 10.1016/j.jbi.2019.103252 – ident: e_1_2_8_21_2 doi: 10.3934/mbe.2021418 – ident: e_1_2_8_22_2 doi: 10.1097/MD.0000000000014144 – ident: e_1_2_8_4_2 doi: 10.1001/jama.2019.0234 – ident: e_1_2_8_10_2 doi: 10.32604/cmes.2021.016728 – ident: e_1_2_8_8_2 doi: 10.12659/MSM.930197 – ident: e_1_2_8_1_2 doi: 10.5812/aapm.111272 – ident: e_1_2_8_19_2 doi: 10.1007/s12652-020-02883-2 – ident: e_1_2_8_26_2 doi: 10.4103/ija.IJA_168_21 – ident: e_1_2_8_25_2 doi: 10.4103/aer.AER_153_17 – ident: e_1_2_8_5_2 doi: 10.3892/etm.2020.8787 – ident: e_1_2_8_9_2 doi: 10.1001/jamasurg.2017.1505 – ident: e_1_2_8_12_2 doi: 10.1016/j.future.2020.03.039 – ident: e_1_2_8_29_2 doi: 10.1016/j.bjan.2020.08.005 – ident: e_1_2_8_2_2 doi: 10.1016/j.bbi.2020.10.008 – ident: e_1_2_8_3_2 doi: 10.1016/j.jcrc.2016.10.026 – ident: e_1_2_8_17_2 doi: 10.3390/molecules26123671 – ident: e_1_2_8_6_2 doi: 10.25122/jml-2019-0070 – ident: e_1_2_8_15_2 doi: 10.1007/s00432-019-03102-y – ident: e_1_2_8_23_2 doi: 10.12659/MSM.929949 – ident: e_1_2_8_11_2 doi: 10.1016/j.ijcce.2020.12.004 – ident: e_1_2_8_30_2 doi: 10.3892/etm.2017.4335 – ident: e_1_2_8_28_2 doi: 10.4314/ahs.v18i4.48 – reference: 38230094 - Biomed Res Int. 2024 Jan 9;2024:9862705. doi: 10.1155/2024/9862705 |
SSID | ssj0000816096 |
Score | 2.3186164 |
SecondaryResourceType | retracted_publication |
Snippet | Dexmedetomidine (Dex) is an alpha-2 agonist used for sedation during various procedures. Dex activates 2-adrenoceptors, and causes the decrease of sympathetic... Dexmedetomidine (Dex) is an alpha‐2 agonist used for sedation during various procedures. Dex activates 2‐adrenoceptors, and causes the decrease of sympathetic... |
SourceID | pubmedcentral proquest gale pubmed crossref hindawi |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4008941 |
SubjectTerms | Algorithms Analgesia Anesthesia Artificial intelligence Bayes Theorem Bayesian analysis Blood pressure Cardiovascular disease Classification Decision trees Dexmedetomidine Dexmedetomidine - pharmacology Dosage Dosage and administration Dose-response relationship (Biochemistry) Drug dosages Gynecology Heart Rate Hemodynamic responses Humans Hypnotics and Sedatives - pharmacology Hypnotics and Sedatives - therapeutic use Injection K-nearest neighbors algorithm Laparoscopy Methods Optimization Pain perception Patients Perioperative care Pharmacology, Experimental Probability Probability distribution Receptors (physiology) Side effects Surgery Sympathetic nervous system |
SummonAdditionalLinks | – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS9xAEB-qUPGltLXaWFu2YJ9K8C77lX08epWjYBFRuIdCyG42eqDJ0UTqn9-ZZC94arGPyc7uhvnYmdnd_AbgMDVSO13qWPkijUVe8Dj3iYmdxnAAk9xSdqA-Jz_V7EL8mMt5AElqHh_ho7ej9Dw5QlVLDf2gvpEqUt6z2XzYSqHaESPTl5EbC0yGOF9dcX_Qfc35hCX45RUlv38WT4WYD29K3nM9x6_hVYgZ2aQX8ht44au3sHUSTsV34NekqDvLZ3XJpv4OR_JtfbNAt-TZomLTUASlZdO68Q3L23uvzqms1yWRnaIy1kvfQ4Gz0x5wtXkHF8ffz7_N4lA1IXZCqxYXVVQO50c2ccpaSp9ynisz7pD7nMcAJCmtSXKURmJKzUvkj8utczb3RWId34XNqq78e2BozNpY7OB8IbQbWS_SER2slZbLUrkIvq7YmbkAKU6VLa6zLrWQMiPmZ4H5EXwZqJc9lMY_6A5IMhlZGI7mUN9dNtFjFOtYcxnBYZDYc6OsxJkFs2yyRBkulUH9jODz0EwT0FWzyte3HY0QBHJvItjrpT9MxGWqqUBABHpNLwYCAuteb6kWVx1ot6HFVKT7__f1H2CbHvu9ngPYbH_f-o8Y_bT2U6f7fwEysPrl priority: 102 providerName: Hindawi Publishing – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwEB5BEagXxJtAQUYqJxR1E9txfEIrlqVCKuqhlXpAiuKJ064EyZakgp_PTOINXcTjGk_sxDMez4yt7wPYz602aGoTZ77KY1VWMi59amM0FA5QklvrAdTn6FN2eKo-numzUHDrwrXKjU8cHHXVItfID9LMSp1Z6vrt-jJm1ig-XQ0UGjfhVkI7Ddt5vvww1ViYVGJmR365RFGWJOXm7rvWnPanB2TCuVXJ1q4UfPPtC86Kv6_-FHv-foXy2p60vAd3QzAp5qP278MN3zyAO0fhuPwhfJ5X7eASRFuLhf9BPfm-_bqi_cqLVSMWgR2lF4u2850o-2uPTpjv65zFjslK27UfMcLF8YjE2j2C0-X7k3eHcaBTiFGZrCdvS1aDfuZSzJzjvKqUZWaTAdIPPUUmae1sWpKaUlsbWdP8YOkQXemr1KF8DDtN2_inIGiVG-voBfSVMjhzXuUzPnGrndR1hhG82UxngQFrnCkvvhRDzqF1wZNfhMmP4PUkvR4xNv4it8eaKXjpUW9ICwGLuUlIrYmROoL9oLH_9bJRZxHWa1f8sq4IXk3NPADfQWt8ezXIKMXo9zaCJ6P2p4Gkzg0zB0RgtuxiEmAU7-2WZnUxoHlb9rIqf_bvz3oOu_wTY_FnD3b6b1f-BYVDvXs52PxPfA0FXA priority: 102 providerName: ProQuest |
Title | Adoption of Dexmedetomidine in Different Doses at Different Timing in Perioperative Patients |
URI | https://dx.doi.org/10.1155/2022/4008941 https://www.ncbi.nlm.nih.gov/pubmed/35872874 https://www.proquest.com/docview/2693569957 https://www.proquest.com/docview/2694420669 https://pubmed.ncbi.nlm.nih.gov/PMC9307348 |
Volume | 2022 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9swEBZdy8Zexn523rqgQfc0vMWWJVkPY2RLszBICaGBwBjGkuUl0Nlt47Luv9-dLIemdGwvBttnCe6-O93Z8neEHKaKSyNLGQpbpGGSFyzMbaxCIyEdgCK35I7UZ3IsxvPk64IvdkjXbdQrcH1raYf9pOYXp--uzn9_BIf_4Byec6zf4_eAxVThH-x7sCYJLMMmPtF3MTmNRF-1neaiBOolxrpd8DcG2FqffJS-u8T6-Nfqtiz05mbKa6vT6CF54NNKOmhx8Ijs2OoxuTfxH86fkOW3mW0cM3PxnQ6K2gUKWpd0aK9gVNvUP1ewilm6qujQ90xp6LBe2zXNm2uXTrAL2A8UmwJ2QVctczidtvys66dkPjo6-TwOfZOF0CRSNBCDAUvG9nVshNZYbeUsFypyRH_GQr4Sl1rFORgvVqVkJejK5NoYndsi1oY9I7tVXdnnhILvS6XhAWOLRJq-tknax-9wpWa8FCYgbzvVZsYzkGMjjNPMVSKcZ2iIzBsiIG820mct88Zf5A7QShlCBBUJ7mGygYzAxJFkPCCH3nr_GqUzbdaBMIuFYlwogHNAXm9u4wS4M62y9aWTSRLkxFcB2W-RsJmI8VRiP4GAyC2MbASQ23v7TrVaOo5vhbE3SV_8pxJekvt42r4bOiC7zcWlfQXZUqN75I5cSDimoy89svfp6Hg66znngONsvPgDg1UR5w |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIh4XxJtAASO1JxR149hxfEBoxVJtabfqYSvtASnEjkNXgmQhqQp_it_ITF50EY9Tr8nsJDtPz9iZD2A71lJZlSs_clnsizQL_dRx7VuFywEscnPZDPWZHUXTE_FuIRcb8KP_FoaOVfYxsQnUWWmpR77LIx3KSCPr16svPqFG0e5qD6HRmsWB-36OJVv1an-C-t3hfO_t_M3U71AFfCtUVGPQQeFZNzLcRsZQeZGGaaSDZrKddZigeW40T_Ftuc5VmGOWs6mx1qQu48aGyPcKXBXUGUf_UQs19HQIxGKkWzy7QGBVFob9WXspqc3Ad9FlYi2CtSzY5YJrp1SFny__tNb9_cjmhRy4dxtudYtXNm6t7Q5suOIuXJ912_P34P04K5sQxMqcTdw35OTq8vMS86Njy4JNOjSWmk3KylUsrS9cmhO-2EciO0avKFeunUnOjtvJr9V9OLkUQT-AzaIs3CNgGFWUNvgD6zKh7Mg4EY9ohy83ocwj68HLXpyJ7WabE8TGp6SpcaRMSPhJJ3wPdgbqVTvT4y90W6SZhFwduVl0PJuMVYBqDVQoPdjuNPY_Lr06ky4-VMkva_bgxXCbHkBn3gpXnjU0QtC0fe3Bw1b7w4NCGStCKvBArdnFQEBTw9fvFMvTZnq4pqgu4sf_fq3ncGM6nx0mh_tHB0_gJv2htvG0BZv11zP3FJditXnW2D-DD5ftcD8BFPFD5w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db5RAcFJrbHwxfla06pq0T4bcsQss-2DMRby01jb30Cb3YILssthLFE6hqf41f50zsJw948dTX9lhgPme3WEGYDdRkTSylH5si8QP80L4ueXKNxLDAUxyy6hr6nN0HO-fhm_n0XwDfgz_wlBZ5WATO0Nd1Ib2yEc8ViKKFaIela4sYpZOXy2_-DRBik5ah3EavYgc2u8XmL41Lw9S5PUe59M3J6_3fTdhwDehjFs0QEhIY8eam1hrSjVykccq6LrcGYvOmpda8RzfnKtSihI9nsm1MTq3BddGIN5rcF0KjKpQl-RcrvZ3aKDFWPWz7YIQMzQhhrr7KKItBz5C9UlUGKx5ROcXbpxRRn6x-FPc-3v55iV_OL0Nt1wgyya95N2BDVvdha0jd1R_D95PirozR6wuWWq_ISbb1p8X6CstW1QsdZNZWpbWjW1Y3l66dEKzxj4S2Aw1pF7avj85m_VdYJv7cHolhH4Am1Vd2YfA0MJIpfEGY4tQmrG2YTKm075Si6iMjQcvBnJmxvU5p3Ebn7Iu34mijIifOeJ7sLeCXvb9Pf4Ct0OcyUjtEZtBJTTZRAbI1gDZ78Gu49j_sAzszJytaLJfku3B89UyPYDq3ypbn3cwYUid95UH2z33Vw8SUSJpaoEHck0uVgDUQXx9pVqcdZ3EFVn4MHn079d6Bluoatm7g-PDx3CTvqffg9qBzfbruX2CUVmrn3biz-DDVevbT1h7SCY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%5BRetracted%5D+Adoption+of+Dexmedetomidine+in+Different+Doses+at+Different+Timing+in+Perioperative+Patients&rft.jtitle=BioMed+research+international&rft.au=Xie%2C+Jing&rft.au=Feng%2C+Shiqiang&rft.au=Qu%2C+Zhenhua&rft.date=2022&rft.issn=2314-6133&rft.eissn=2314-6141&rft.volume=2022&rft.issue=1&rft_id=info:doi/10.1155%2F2022%2F4008941&rft.externalDBID=n%2Fa&rft.externalDocID=10_1155_2022_4008941 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2314-6133&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2314-6133&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2314-6133&client=summon |